Vascular endothelial growth factor in astroglioma stem cell biology and response to therapy
Abstract
Malignant astrogliomas are among the most aggressive, highly vascular and infiltrating tumours bearing a dismal prognosis, mainly due to their resistance to current radiation treatment and chemotherapy. Efforts to identify and target the mechanisms that underlie astroglioma resistance have recently focused on candidate cancer stem cells, their biological properties, interplay with their local microenvironment or 'niche', and their role in tumour progression and recurrence. Both paracrine and autocrine regulation of astroglioma cell behaviour by locally produced cytokines such as the vascular endothelial growth factor (VEGF) are emerging as key factors that determine astroglioma cell fate. Here, we review these recent rapid advances in astroglioma research, with emphasis on the significance of VEGF in astroglioma stem-like cell biology. Furthermore, we highlight the unique DNA damage checkpoint properties of the CD133-marker-positive astroglioma stem-like cells, discuss their potential involvement in astroglioma radioresistance, and consider the implications of this new knowledge for designing combinatorial, more efficient therapeutic strategies.Citation
Journal of Cellular and Molecular Medicine, 12(1): 111-125Publisher
Wiley InterScienceJournal
Journal of Cellular and Molecular MedicinePubMed ID
18031298Additional Links
http://www3.interscience.wiley.com/journal/119424038/abstract.xType
Journal articleLanguage
enISSN
1582-1838ae974a485f413a2113503eed53cd6c53
10.1111/j.1582-4934.2007.00153.x
Scopus Count
Collections
Related articles
- Glioma stem cells promote radioresistance by preferential activation of the DNA damage response.
- Authors: Bao S, Wu Q, McLendon RE, Hao Y, Shi Q, Hjelmeland AB, Dewhirst MW, Bigner DD, Rich JN
- Issue date: 2006 Dec 7
- Cancer: stem cells and brain tumours.
- Authors: Dirks PB
- Issue date: 2006 Dec 7
- The prognostic value of clinical factors and cancer stem cell-related markers in gliomas.
- Authors: Dahlrot RH
- Issue date: 2014 Oct
- Correlation of altered expression of the autophagy marker LC3B with poor prognosis in astrocytoma.
- Authors: Winardi D, Tsai HP, Chai CY, Chung CL, Loh JK, Chen YH, Hsieh CL
- Issue date: 2014
- Targeting brain-tumor stem cells.
- Authors: Stupp R, Hegi ME
- Issue date: 2007 Feb